Loading...
Cancer Drug Delivery: Considerations in the Rational Design of Nanosized Bioconjugates
[Image: see text] In order to efficiently deliver anticancer agents to tumors, biocompatible nanoparticles or bioconjugates, including antibody–drug conjugates (ADCs), have recently been designed, synthesized, and tested, some even in clinical trials. Controlled delivery can be enhanced by changing...
Saved in:
| Published in: | Bioconjug Chem |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Chemical
Society
2014
|
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4275162/ https://ncbi.nlm.nih.gov/pubmed/25385142 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/bc500481x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|